BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8209275)

  • 21. Paclitaxel and carboplatin as neoadjuvant chemotherapy in operable (stage I and II) and locally advanced (stage IIIA-N2) non-small cell lung cancer.
    Splinter TA
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):59-61. PubMed ID: 9007124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
    J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group.
    Huber RM; Flentje M; Schmidt M; Pöllinger B; Gosse H; Willner J; Ulm K;
    J Clin Oncol; 2006 Sep; 24(27):4397-404. PubMed ID: 16983107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platinum-based chemotherapy in non-small cell lung cancer: the experience of the European Organization for the Research and Treatment of Cancer.
    van Zandwijk N; Dalesio O
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):66-71. PubMed ID: 8052876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combination radiotherapy and chemotherapy in bronchial cancer: benefits and limitations].
    Mirimanoff RO
    Schweiz Med Wochenschr; 1990 May; 120(18):680-6. PubMed ID: 2160727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination chemotherapy and radiation therapy in lung cancer.
    Sause WT
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):72-8. PubMed ID: 8052877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trials with mitomycin, ifosfamide and cisplatin in non-small cell lung cancer.
    Cullen MH
    Lung Cancer; 1995 Apr; 12 Suppl 1():S95-106. PubMed ID: 7551939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy regimens for non-small cell lung cancer.
    Loi M; Roche N; Alifano M
    Minerva Chir; 2009 Dec; 64(6):629-41. PubMed ID: 20029359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous hyperfractionated accelerated radiotherapy (CHART) and non-conventionally fractionated radiotherapy in the treatment of non-small cell lung cancer: a review and consideration of future directions.
    Hatton MQ; Martin JE
    Clin Oncol (R Coll Radiol); 2010 Jun; 22(5):356-64. PubMed ID: 20399629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial".
    Holoye PY
    Cancer Treat Rep; 1987 Apr; 71(4):431-2. PubMed ID: 3030548
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adjuvant therapy of surgically treated non-small cell lung cancer].
    Depierre A; Jacoulet P
    Rev Pneumol Clin; 1992; 48(5):237-41. PubMed ID: 1338936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomised comparison of radical radiotherapy with or without chemotherapy for patients with non-small lung cancer: results from the Big Lung Trial.
    Fairlamb D; Milroy R; Gower N; Parmar M; Peake M; Rudd R; Souhami R; Spiro S; Stephens R; Waller D
    Radiother Oncol; 2005 May; 75(2):134-140. PubMed ID: 16094738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant and neo-adjuvant chemotherapy in non-small cell carcinoma.
    Cullen MH
    Ann Oncol; 1995; 6 Suppl 1():43-7; discussion 47-8. PubMed ID: 8695544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preliminary results concerning the value of chemotherapy in the treatment of inoperable bronchial carcinoma (excluding small-cell anaplastic carcinoma)].
    Quoix E; Pelletier A; Schaller M; Pillement P; Dietemann-Molard A; Klein T; Spielmann P; Orion B; Chaix C
    Rev Pneumol Clin; 1984; 40(2):127-9. PubMed ID: 6374840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer.
    Cullen MH
    Oncology; 1993 Apr; 50 Suppl 1():31-4. PubMed ID: 8387176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis.
    Marino P; Preatoni A; Cantoni A
    Cancer; 1995 Aug; 76(4):593-601. PubMed ID: 8625152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant therapy for resected non-small-cell lung cancer: past, present, and future.
    Juergens RA; Brahmer JR
    Curr Oncol Rep; 2005 Jul; 7(4):248-54. PubMed ID: 15946582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is control of the primary tumour worthwhile in non-oat cell carcinoma of the bronchus?
    Saunders MI
    Clin Oncol (R Coll Radiol); 1991 Jul; 3(4):185-8. PubMed ID: 1657111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy and radiotherapy for regionally advanced non-small-cell lung cancer.
    Elias A
    Chest; 1993 Apr; 103(4 Suppl):362S-366S. PubMed ID: 8384971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The management of lung cancer: a UK survey of oncologists.
    Prewett SL; Aslam S; Williams MV; Gilligan D
    Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):402-9. PubMed ID: 22516859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.